[1] A. Bajer et al., “Babesiosis in southeastern, central and northeastern Europe: An rising and re-emerging tick-borne illness of people and animals,” Microorganisms, vol. 10, no. 5, p. 945, 2022.
[2] E. Montero, J. Grey, C. A. Lobo, and L. M. González, “Babesia and Human Babesiosis,” Pathogens, vol. 11, no. 4, p. 399, Mar. 2022.
[3] L. T. S. Santos, “Era of polyclonal and monoclonal antibodies in opposition to Babesia ovis protein extract (Doctoral dissertation),” Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, 2020.
[4] E. Vannier, B. E. Gewurz, and P. J. Krause, “Human babesiosis,” Infect. Dis. Clin. North Am., vol. 22, no. 3, pp. 469–88, viii–ix, 2008.
[5] T. Okay. Chen and P. J. Krause, “Human Babesiosis,” in Medical Infectious Illness, D. Schlossberg, Ed. Cambridge: Cambridge College Press, 2013, pp. 1381–1388.
[6] S. Wang et al., “Institution of a transient and steady transfection system for Babesia duncani utilizing a homologous recombination technique,” Entrance. Cell. Infect. Microbiol., vol. 12, p. 844498, 2022.
[7] M. Swanson, “Surveillance for Babesiosis,” Facilities for Illness Management and Prevention, 2021. [Online].
[8] R. L. Ord and C. A. Lobo, “Human babesiosis: Pathogens, prevalence, analysis and therapy,” Curr. Clin. Microbiol. Rep., vol. 2, no. 4, pp. 173–181, 2015.
[9] M. J. Homer, I. Aguilar-Delfin, S. R. Telford third, P. J. Krause, and D. H. Persing, “Babesiosis,” Clin. Microbiol. Rev., vol. 13, no. 3, pp. 451–469, 2000.
[10] J. S. Shah, N. S. Harris, I. R. Horowitz, and R. Horowitz, “Human Babesiosis and Ehrlichiosis -Present Standing,” Igenex.com. [Online]
[11] A. Zintl, G. Mulcahy, H. E. Skerrett, S. M. Taylor, and J. S. Grey, “Babesia divergens, a bovine blood parasite of veterinary and zoonotic significance,” Clin. Microbiol. Rev., vol. 16, no. 4, pp. 622–636, 2003.
[12] A. Kumar, J. O’Bryan, and P. J. Krause, “The worldwide emergence of human babesiosis,” Pathogens, vol. 10, no. 11, p. 1447, 2021.
[13] E. Vannier and P. J. Krause, “Replace on babesiosis,” Interdiscip. Perspect. Infect. Dis., vol. 2009, p. 984568, 2009.
[14] CDC-Facilities for Illness Management and Prevention, “CDC – Babesiosis – epidemiology & danger components,” 2010.
[15] S. C. Parija, D. Kp, and H. Venugopal, “Prognosis and administration of human babesiosis,” Trop. Parasitol., vol. 5, no. 2, pp. 88–93, 2015.
[16] J. G. Schneider, B. S. Mt, and J. S. Dumler, “Clin Lab Sci 2009;22(1):3,” Ascls.org. [Online]
[17] A. S. Paul, C. Okay. Moreira, B. Elsworth, D. R. Allred, and M. T. Duraisingh, “Intensive shared chemosensitivity between malaria and babesiosis blood-stage parasites,” Antimicrob. Brokers Chemother., vol. 60, no. 8, pp. 5059–5063, 2016.
